This inventor holds 13 USPTO granted patents. Top assignees: Burroughs Wellcome Co., Other. Active years: 1985-1988.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Bromley, Kent, GB (1985 - 1986)
- Bromley, GB (1985 - 1988)
Company Filing History:
Years Active: 1985-1988
Title: Geoffrey G Coker: Innovator in Antihistamine Compounds
Introduction
Geoffrey G Coker is a notable inventor based in Bromley, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antihistamine compounds. With a total of 13 patents to his name, Coker's work has had a considerable impact on the medical community.
Latest Patents
Coker's latest patents include innovative compounds such as Piperazinyl benzyl acids, which exhibit antihistamine activity. These compounds are characterized by a specific formula that allows for various derivatives, including salts, esters, and amides. Additionally, he has developed Pyridylvinyl-1H tetrazole, which also demonstrates antihistamine properties. These inventions not only provide new therapeutic options but also include pharmaceutical formulations and methods for their preparation.
Career Highlights
Throughout his career, Geoffrey G Coker has worked with prominent companies, including Burroughs Wellcome Co. His extensive experience in the pharmaceutical industry has enabled him to focus on the development of effective antihistamine medications. His contributions have been recognized within the scientific community, further establishing his reputation as an innovator.
Collaborations
Coker has collaborated with notable individuals in his field, including John W Findlay and John D McDermed. These partnerships have likely enhanced the quality and scope of his research and inventions.
Conclusion
Geoffrey G Coker's work in the development of antihistamine compounds showcases his innovative spirit and dedication to improving healthcare. His numerous patents reflect his commitment to advancing pharmaceutical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile